Clinical Trial Update: A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) [Phase 1, Phase 2]

View source ↗

Summary

A pediatric Phase 1/2 study of pembrolizumab (Keytruda) in children with advanced solid tumors or lymphoma is currently recruiting. The trial investigates safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Melanoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Melanoma, Lymphoma | Phase 1, Phase 2 | Status: RECRUITING